Canadian Journal of Anesthesia

, Volume 50, Issue 6, pp 621–622 | Cite as

In vitro relationship between the blood nafamostat concentration and activated coagulation time

  • Hiroshi Iwama
  • Kazuhiro Watanabe
  • Shinju Obara


Coronary Artery Bypass Grafting Aspiration Pneumonia Activate Coagulation Time Mesilate Nafamostat 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Aoyama T. Nafamstat mesilate. Drugs of the Future 1984; 9: 747–8.Google Scholar
  2. 2.
    Hu ZJ, Iwama H, Suzuki R, Kobayashi S, Akutsu I. Time course of activated coagulation time at various sites during continuous haemodiafiltration using nafamostat mesilate. Intensive Care Med 1999; 25: 524–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Kox WJ, Rohr U, Wauer H. Practical aspects of renal replacement therapy. Int J Artif Organs 1996; 19: 100–5.PubMedGoogle Scholar

Copyright information

© Canadian Anesthesiologists 2003

Authors and Affiliations

  • Hiroshi Iwama
    • 1
  • Kazuhiro Watanabe
    • 1
  • Shinju Obara
    • 1
  1. 1.AizuwakamatsuJapan

Personalised recommendations